Factors for rapid and sustained hematopoietic reconstitution by circulating progenitor-cell transplantation in non-Hodgkin's lymphoma

Cancer Chemotherapy and Pharmacology, Supplement

Volumn 38, Issue , 1996, Pages

  Barbui, Tiziano ^a   Cortelazzo, Sergio ^a   Rossi, Andrea ^a   Viero, Piera ^a   Bellavita, Piero ^a   Buelli, Maurizio ^a   Fracassetti, Dario ^a   Bassan, Renato ^a   Comotti, Benedetto ^a   Marchioli, Roberto ^b   Marfisi, Rosa Maria ^b   Rambaldi, Alessandro ^a  

^a OSPEDALI RIUNITI   (Italy)

^b MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

Author keywords

CD34+ cells; G CSF; Long term sustained hematologic reconstitution; Non Hodgkin's lymphoma; Short term hematologic reconstitution

Indexed keywords

CARMUSTINE; CD34 ANTIGEN; CYTARABINE; ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR; MELPHALAN;

ADULT; CLINICAL TRIAL; CONFERENCE PAPER; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; NONHODGKIN LYMPHOMA; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0029789535     PISSN: 09439404     EISSN: None     Source Type: Journal    
DOI: 10.1007/pl00006735     Document Type: Conference Paper

References (14)

1. Botnik LE, Hannon EC, Obbagy J, Hellman S (1982) The variation of hematopoietic stem cell self-renewal capacity as a function of age: further evidence for heterogenicity of the stem cell compartment. Blood 60: 268
2. Coiffier B, Philip T, Burnett AK, Symann ML (1994) Consensus conference on intensive chemotherapy plus hematopoietic stem-cell transplantation in malignancies: Lyon, France, June 4-6, 1993. J Clin Oncol 12: 226
3. Cortelazzo S, Viero P, Bellavita P, Rossi A, Buelli NJ, Borleri GM, Marziali S, Bassan R, Comotti B, Rambaldi A, Barbui T (1995) Granulocyte colony-stimulating factor following peripheral-blood progenitor-cell transplant in non-Hodgkin lymphoma. J Clin Oncol 13: 935
4. Gianni AM, Bonadonna G (1989) High dose chemo-radiotherapy for sensitive tumors: is sequential better than concurrent drug delivery? Eur J Cancer Clin Oncol 25: 1027
5. Haas R, Witt B, Mohle R, Goldschmidt H, Hohaus S, Fruehauf S, Wannenmacher M, Hunstein W (1995) Sustained long-term hematopoiesis after myeloablative therapy with peripheral blood progenitor cell support. Blood 12: 3754
6. Juttner CA, Fibbe WE, Nemunaitis J, Kanz L, Gianni AM (1994) Blood cell transplantation: report from the International Consensus Meeting. Bone Marrow Transplant 14: 689
7. Klumpp T, Mangan KF, Goldberg SL, Pearlman ES, Macdonald JS (1995) Granulocyte colony-stimulating factor accelerates neutrophil engraftment following peripheral-blood stem cell transplantation: a prospective, randomized trial. J Clin Oncol 13: 1323
8. Lipschitz DA, Udupa KB, Milton KY, Thompson CO (1984) Effect of age on hematopoiesis in man. Blood 3: 502
9. Schwartzberg L, Birch R, Blanco R, Wittlin F, Muscato J, Tauer K, Hazelton B, West W (1993) Rapid and sustained hematopoietic reconstitution by peripheral blood stem cell infusion alone following high-dose chemotherapy. Bone Marrow Transplant 11: 369
10. Siena S, Bregni M, Brando B, Belli N, Ravagnani F, Gandola L, Stern AC, Lansdorp PM, Bonadonna G, Gianni AM (1991) Flow cytometry for clinical estimation of circulating hematopoietic progenitors for autologous transplantation in cancer patients Blood 77: 400
11. Siena S, Bregni M, Di Nicola M, Ravagnani F, Peccatori F, Gandola L, Lombardi F, Tarella C, Bonadonna G, Gianni AM (1994) Durability of hematopoiesis following autografting with peripheral blood hematopoietic progenitors. Ann Oncol 5: 935
12. Spitzer G, Adkins DR, Spencer V, Dunphy FR, Petruska PJ, Velasquez WS, Bowers CE, Kronmueller N, Niemeyer R, McIntyre W (1994) Randomized study of growth factors post-peripheral blood stem-cell transplant: neutrophil recovery is improved with modest clinical benefit. J Clin Oncol 12: 661
13. Stella CC, Cazzola M, De Fabritiis P, De Vincentiis A, Gianni AM, Lanza F, Lemoli RM, Tarella C, Zanon P, Tura S (1995) CD-34 positive cells: biology and clinical relevance. Haematologica 80: 367
14. Velasquez WS, Cabanillas F, Salvador P, McLaughlin P, Fridrik M, Tucker S, Jagannath S, Hagemeister FB, Redman JR, Swan F, Barlogie B (1988) Effective salvage therapy for lymphoma with cisplatin in combination with high-dose Ara-C and dexamethasone (DHAP). Blood 71: 117